Current and Emerging Strategies in Antiplatelet Therapy for Acute Coronary Syndrome

At the conclusion of this educational activity, participants should be better prepared to: Incorporate appropriate testing of cytochrome P450 genetic polymorphisms and adjust antiplatelet therapies accordingly Formulate and adjust antiplatelet therapy for patients with ACS who are at high risk for bleeding Evaluate the potential role of platelet function testing in patients at risk for recurrent thrombotic events or bleeding Select appropriate antiplatelet therapy for patients with ACS, continually integrating Level 1 evidence with clinical evaluation of risks and benefits Coordinate care of patients with primary care physicians following discharge